和铂医药控股有限公司（股票代码：02142，以下简称“和铂医药-B”）于2026年8月6日发布截至2026年7月31日的月度证券变动报告。公告显示，公司本月维持20,000,000,000股法定/注册股本不变，股本面值每股0.000025美元，总面值仍为500,000美元。
在已发行股份及库藏股份方面，截至本月末，和铂医药-B普通股总发行量由上月的868,341,722股增加至869,142,522股；库藏股份保持在31,834,000股不变，使得公司本月末全部已发行股份合计900,976,522股，相比上月底增加800,800股。
根据公告，报告期内有800,800股普通股因“首次公开发售后购股权计划”而行使增发，持股人合计获得资金2,304,264港元。公司同时披露了“首次公开发售后股份奖励计划”，尚有28,463,058股可能根据该计划发行或从库藏股转让，但报告期内并未发生新增或转让记录。
公告显示，和铂医药-B确认在本月末继续满足联交所关于最低公众持股量的相关规定。公司亦确认已遵守所有适用上市规则及相关法律要求，并完成了相应的内部程序。此次公告由执行董事王劲松签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.